News Archives - Page 82 of 87

TuesdayJul 05, 2022 12:11 pm

TinyGemsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Eliminates $17.5M in Debt, in Best Financial Health in Company History

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has eliminated $17.5 million in company debt, resulting in a reduction of debt from more than $30 million last year to an estimated $11 million currently. The eliminated debt was related to a secured convertible promissory note with DBI Lease Buyback Servicing LLC, an affiliate of Drawbridge Investments LLC. The announcement noted that the company is committed to strengthening its overall financial balance sheet and currently is in the best financial health in its history. “We continue to make great progress on our overall company financial health,” said Mullen Automotive CEO…

ThursdayJun 30, 2022 1:30 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Expects to Report >$61M in Cash, Cash Equivalents After Significantly Strengthening Balance Sheet

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it expects to report in excess of $61 million in cash and cash equivalents on June 30, 2022, after having significantly strengthened its balance sheet over the quarter-ending June 30, 2022. In the update, Mullen restated previously released highlights, including recent delivery of its first EV van under a pilot program to a telecommunications provider in the southeastern part of the U.S., payoff of a secured convertible promissory note executed on July 23, 2020, with DBI Lease Buyback Servicing LLC, as well as the company’s addition to…

TuesdayJun 28, 2022 1:10 pm

TinyGemsBreaks – GreenBox POS (NASDAQ: GBOX) Issues Letter to Shareholders

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing financial technology company, today announced a CEO letter to shareholders. In the letter, GBOX Chief Executive Officer Fredi Nisan discussed the company’s maturation over the years and his encouragement in the company’s accomplishments and future. “No doubt, we are keenly aware of volatile changes in the competitive landscape and business environment that have left numerous organizations rethinking their strategy. Nonetheless, we remain laser-focused on the long-term execution of our business strategy, with steadfast confidence in our highly differentiated technology,” Nisan stated. “Our commitment to driving shareholder value is not, and should not,…

TuesdayJun 28, 2022 12:44 pm

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), Adelia Announce Achievement of Milestone

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, a biotechnology company focused on progressing Psychedelics to Therapeutics(TM), and its wholly controlled subsidiary Adelia Therapeutics Inc., have announced the achievement of a key milestone. The milestone is identified as Y2, Q3 in the contribution agreement created between Adelia and Cybin when the company acquired Adelia. Reaching the milestone means that an estimated 37,366.2 class B common shares in Cybin will be issued to Adelia shareholders; the issuance of the shares represents the approximately $217,465 that Cybin agreed to pay if the key milestone was achieved. Adelia…

MondayJun 27, 2022 2:04 pm

TinyGemsBreaks – Cepton Inc. (NASDAQ: CPTN) Expands Collaboration Efforts with Tier 1 Supplier of Automotive Lighting Equipment

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, and Koito Manufacturing Co. Ltd (TSE: 7276), a leading automotive lighting equipment tier-1 supplier, jointly announced their intention to expand existing collaboration efforts to include select future Cepton lidar products and go-to-market activities. According to the update, detailed commercial terms are under discussion. “In the past five years, our team has successfully collaborated with Koito to commercialize and scale the manufacturing of Cepton’s lidar technology,” said Jun Pei, Cepton’s co-founder and CEO. “Expanded collaboration will further strengthen the Koito-Cepton partnership and better positions both companies to…

MondayJun 27, 2022 1:46 pm

TinyGemsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Moving Forward with Phase 1/2a Clinical Trial after Receiving Key FDA Approval

Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on progressing psychedelic therapeutics, has received approval from the U.S. Food and Drug Administration (“FDA”) to proceed with its phase 1/2a first-in-human clinical trial evaluating CYB003; the company has received a “may proceed” letter and investigational new drug application (“IND”) clearance from the FDA. The approval means that CYB003 will be the first novel psilocybin analog to enter clinical development, with patient recruitment beginning immediately and pharmacokinetic and safety data readout anticipated by fourth quarter 2022. According to the announcement, Cybin’s CYB003 is a proprietary deuterated psilocybin analog being developed for…

FridayJun 24, 2022 12:23 pm

TinyGemsBreaks – GreenBox POS (NASDAQ: GBOX) Becomes Among Sector’s 1st to Ensure Real-Time Custodial Account Attestations

GreenBox (NASDAQ: GBOX) is a financial technology company that leverages proprietary blockchain security and token technology to deliver customized payment solutions. The company has consistently called for improved processes to make the stablecoin industry custodial and transactional — the two elements GreenBox believes are critical to the industry’s long-term success. Upon completing a rigorous process, GreenBox has announced a partnership with accounting and consulting firm Armanino to attest to all GreenBox custodial accounts in real-time. “I could not be more pleased to see the stablecoin industry and the regulators move in the direction GreenBox has built our company on since…

ThursdayJun 23, 2022 4:33 pm

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Secures FDA Approval for Protocol Amendment to Ongoing Potentially Pivotal Berubicin Trial

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company today announced its receipt of approval from the U.S. Food and Drug Administration (“FDA”) for its ongoing potentially pivotal global study evaluating the efficacy and safety of Berubicin compared with Lomustine (Gleostine) administered after first line therapy for the treatment of recurrent glioblastoma multiforme (“GBM”), one of the most aggressive types of brain cancer. “We are pleased to have received this positive response from the FDA and to continue driving the…

ThursdayJun 23, 2022 3:11 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Issues Shareholder Update

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today provided an update to its shareholders, including recent highlights and accomplishments for the company, the Mullen FIVE and the Mullen EV Van programs. Among the various highlights, the company reported that its solid-state polymer battery cell was successfully tested for the second time at Battery Innovation Center (“BIC”) in Indiana. The follow-up testing through an accredited facility shows promise for solid-state polymer cell technology when scaled to the vehicle pack level and used in EVs. “2022 has been an exceptional year for us so far; I am very proud…

WednesdayJun 22, 2022 3:08 pm

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Files 130+ US, International Patent Applications for Mullen FIVE EV Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has filed over 130 patents in 24 countries in support of the Mullen FIVE EV Crossover program. Per the update, the 130-plus patent applications relate to Mullen FIVE EV’s design and styling of its exterior and interior. They include areas such as vehicle bodywork, headlights and taillights, doors, mirrors, rims, headliners, seats and steering. “We fully intend to make the Mullen FIVE available around the world, and these patents, including filings in 24 international countries, show our intended commitment to do so,” said David Michery, CEO…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

Breaks Categories: News